(1) Objectives: The aim of this study was to investigate the impact of the prolonged use of continuous-flow left ventricular assist devices (LVADs) on heart transplant (HTx) candidates. (2) Methods: Between January 2012 and December 2019, we included all consecutive patients diagnosed with end-stage heart failure considered for HTx at our institution, who were also eligible for LVAD therapy as a bridge to transplant (BTT). Patients were divided into two groups: those who received an LVAD as BTT (LVAD group) and those who were listed without durable support (No-LVAD group). (3) Results: A total of 250 patients were analyzed. Of these, 70 patients (28%) were directly implanted with an LVAD as BTT, 11 (4.4%) received delayed LVAD implantation,...
Heart transplantation (HTx) improves symptoms and prolongs life in advanced heart failure (HF), but ...
ObjectivesContinuous-flow left ventricular assist devices have become the standard of care for patie...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
(1) Objectives: The aim of this study was to investigate the impact of the prolonged use of continuo...
ObjectiveAlthough left ventricular assist devices (LVADs) are associated with excellent outcomes in ...
The two main surgical options to treat end-stage heart failure are heart transplantation (HTx) or le...
BACKGROUND: Although the left ventricular assist device (LVAD) has been increasingly used as a bridg...
Purpose: Strategies underlying the use of Left ventricular assist devices (LVAD) for patients with e...
ObjectivesThis study sought to evaluate the use of a continuous-flow rotary left ventricular assist ...
Introduction: The improved outcomes of third-generation continuous-flow left ventricular assist devi...
BACKGROUND: Continuous-flow left ventricular assist devices (LVADs) have become the standard of care...
Background: Geographic variations in management and outcomes of individuals supported by continuous-...
Background: Geographic variations in management and outcomes of individuals supported by continuous-...
Long-term continuous-flow left ventricular assist devices (LVAD) as bridge to heart transplantation ...
BACKGROUND: Geographic variations in management and outcomes of individuals supported by continuous-...
Heart transplantation (HTx) improves symptoms and prolongs life in advanced heart failure (HF), but ...
ObjectivesContinuous-flow left ventricular assist devices have become the standard of care for patie...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
(1) Objectives: The aim of this study was to investigate the impact of the prolonged use of continuo...
ObjectiveAlthough left ventricular assist devices (LVADs) are associated with excellent outcomes in ...
The two main surgical options to treat end-stage heart failure are heart transplantation (HTx) or le...
BACKGROUND: Although the left ventricular assist device (LVAD) has been increasingly used as a bridg...
Purpose: Strategies underlying the use of Left ventricular assist devices (LVAD) for patients with e...
ObjectivesThis study sought to evaluate the use of a continuous-flow rotary left ventricular assist ...
Introduction: The improved outcomes of third-generation continuous-flow left ventricular assist devi...
BACKGROUND: Continuous-flow left ventricular assist devices (LVADs) have become the standard of care...
Background: Geographic variations in management and outcomes of individuals supported by continuous-...
Background: Geographic variations in management and outcomes of individuals supported by continuous-...
Long-term continuous-flow left ventricular assist devices (LVAD) as bridge to heart transplantation ...
BACKGROUND: Geographic variations in management and outcomes of individuals supported by continuous-...
Heart transplantation (HTx) improves symptoms and prolongs life in advanced heart failure (HF), but ...
ObjectivesContinuous-flow left ventricular assist devices have become the standard of care for patie...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...